Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey.
ATGen, Montevideo, Uruguay.
J Mol Diagn. 2022 Mar;24(3):189-204. doi: 10.1016/j.jmoldx.2021.11.006. Epub 2021 Dec 23.
SuperSelective primers, by virtue of their unique design, enable the simultaneous identification and quantitation of inherited reference genes and rare somatic mutations in routine multiplex PCR assays, while virtually eliminating signals from abundant wild-type sequences closely related to the target mutations. These assays are sensitive, specific, rapid, and low cost, and can be performed in widely available spectrofluorometric thermal cyclers. Herein, we provide examples of SuperSelective PCR assays that target eight different somatic EGFR mutations, irrespective of whether they occur in the same codon, occur at separate sites within the same exon, or involve deletions. In addition, we provide examples of SuperSelective PCR assays that detect specific EGFR mutations in circulating tumor DNA present in the plasma of liquid biopsies obtained from patients with non-small-cell lung cancer. The results suggest that multiplex SuperSelective PCR assays may enable the choice, and subsequent modification, of effective targeted therapies for the treatment of an individual's cancer, utilizing frequent noninvasive liquid biopsies.
超选择性引物凭借其独特的设计,能够在常规多重 PCR 检测中同时鉴定和定量遗传性参考基因和罕见的体细胞突变,同时几乎消除了与目标突变密切相关的大量野生型序列的信号。这些检测方法灵敏、特异、快速且成本低廉,可在广泛应用的分光荧光热循环仪上进行。本文提供了针对 8 种不同 EGFR 体细胞突变的超选择性 PCR 检测方法的实例,无论这些突变是否发生在同一密码子中,是否发生在同一外显子的不同部位,或者是否涉及缺失。此外,本文还提供了检测非小细胞肺癌患者液体活检中循环肿瘤 DNA 中特定 EGFR 突变的超选择性 PCR 检测方法的实例。结果表明,多重超选择性 PCR 检测方法可能能够通过频繁的非侵入性液体活检,为个体癌症的治疗选择并随后修改有效的靶向治疗方法。